These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1725641)
1. [HTLV-I antibody screening of blood donors]. Schwarzfischer G; Schätzl H; Bäcker U; Weise W; von der Helm K; Deinhardt F Beitr Infusionsther; 1991; 28():29-31. PubMed ID: 1725641 [TBL] [Abstract][Full Text] [Related]
2. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617 [TBL] [Abstract][Full Text] [Related]
3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
4. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA; Tamim H; Almawi WY Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [TBL] [Abstract][Full Text] [Related]
5. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero]. Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256 [TBL] [Abstract][Full Text] [Related]
6. Human T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: increased prevalence in one blood bank unit. Zervou EK; Georgiadou S; Tzilianos M; Georgitsi P; Pournara V; Nousis S; Pappas C; Daskalou L; Vrettou A; Karabini F; Dalekos GN Eur J Intern Med; 2004 Nov; 15(7):422-427. PubMed ID: 15581745 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
8. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Khameneh ZR; Baradaran M; Sepehrvand N Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311 [TBL] [Abstract][Full Text] [Related]
9. [Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina]. Brun RO; Astarloa L; Salomon HE; Biglione MM Medicina (B Aires); 2004; 64(2):125-8. PubMed ID: 15628298 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867 [TBL] [Abstract][Full Text] [Related]
11. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. Mangano AM; Remesar M; del Pozo A; Sen L J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282 [TBL] [Abstract][Full Text] [Related]
12. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups]. Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956 [TBL] [Abstract][Full Text] [Related]
13. Preliminary survey of anti-HTLV-I in northeastern-Thais. Burusrux S; Urwijitaroon Y; Romphruk A; Puapairoj C J Med Assoc Thai; 1995 Nov; 78(11):628-30. PubMed ID: 8576676 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004. Stramer SL; Foster GA; Dodd RY Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837 [TBL] [Abstract][Full Text] [Related]
15. Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery. Shih JW; Lee HH; Falchek M; Canavaggio M; Jett BW; Allain JP; Alter HJ Blood; 1990 Feb; 75(3):546-9. PubMed ID: 2297566 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety. Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205 [No Abstract] [Full Text] [Related]
17. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Kumar H; Gupta PK Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054 [TBL] [Abstract][Full Text] [Related]
19. [The combined immunoenzyme test: anti-HIV-1 and -2 and anti-HTLV-1 in the detection of donors with retrovirus infections]. Dobec M; Jung M; Zupancić-Salek S; Burek V; Mihaljević I; Grgicević D Lijec Vjesn; 1993; 115(5-6):142-5. PubMed ID: 8302133 [TBL] [Abstract][Full Text] [Related]
20. Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil. Namen-Lopes MS; Martins ML; Drummond PC; Lobato RR; ; Carneiro-Proietti AB Transfus Med; 2009 Aug; 19(4):180-8. PubMed ID: 19706135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]